Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
86.13
-2.59 (-2.92%)
Mar 31, 2025, 9:53 AM EDT - Market open

Blueprint Medicines Stock Forecast

Stock Price Forecast

The 21 analysts with 12-month price forecasts for Blueprint Medicines stock have an average target of 124.29, with a low estimate of 76 and a high estimate of 168. The average target predicts an increase of 44.31% from the current stock price of 86.13.

Analyst Consensus: Buy
Target Low Average Median High
Price $76 $124.29 $127 $168
Change -11.76% +44.31% +47.45% +95.05%

Analyst Ratings

The average analyst rating for Blueprint Medicines stock from 22 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 667667
Buy 677778
Hold 555556
Sell 000000
Strong Sell 111111
Total 181920191922

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Morgan Stanley
Morgan Stanley
Hold
Initiates
$120$100
Hold Initiates $120$100 +16.10% Mar 20, 2025
Jefferies
Jefferies
Strong Buy
Initiates
$135
Strong Buy Initiates $135 +56.74% Mar 17, 2025
Scotiabank
Scotiabank
Buy
Initiates
$150
Buy Initiates $150 +74.16% Mar 7, 2025
Citizens Capital Markets
Citizens Capital Markets
Buy
Reiterates
$125
Buy Reiterates $125 +45.13% Mar 3, 2025
JMP Securities
JMP Securities
Buy
Reiterates
$125
Buy Reiterates $125 +45.13% Feb 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
740.00M
from 508.82M
Increased by 45.43%
Revenue Next Year
982.75M
from 740.00M
Increased by 32.80%
EPS This Year
-1.20
from -1.07
EPS Next Year
1.16
from -1.20
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
793.74M180.08M204.04M249.38M508.82M740.00M982.75M1.26B
Revenue Growth
1,093.37%-77.31%13.30%22.22%104.04%45.43%32.80%28.21%
EPS
5.59-11.01-9.35-8.37-1.07-1.201.164.00
EPS Growth
-------246.20%
Forward PE
------74.5421.53
No. Analysts -----242419
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 854.7M 1.1B 1.5B
Avg 740.0M 982.8M 1.3B
Low 675.6M 835.9M 951.8M

Revenue Growth

Revenue Growth 20252026202720282029
High
68.0%
50.0%
57.2%
Avg
45.4%
32.8%
28.2%
Low
32.8%
13.0%
-3.1%

EPS Forecast

EPS 20252026202720282029
High 0.76 4.11 7.58
Avg -1.20 1.16 4.00
Low -2.40 -1.46 0.83

EPS Growth

EPS Growth 20252026202720282029
High - -
556.1%
Avg - -
246.2%
Low - -
-27.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.